SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-023654
Filing Date
2017-04-17
Accepted
2017-04-17 07:00:43
Documents
3
Effectiveness Date
2017-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-2335_26defa14a.htm DEFA14A 89191
2 GRAPHIC g233526bci001.jpg GRAPHIC 2171
3 GRAPHIC g233526bci002.gif GRAPHIC 20815
  Complete submission text file 0001104659-17-023654.txt   122345
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17763520
SIC: 2834 Pharmaceutical Preparations